Patents by Inventor Juliette Tinker

Juliette Tinker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cholera toxin chimera and its use as a staph vaccine
    Patent number: 10576140
    Abstract: The present invention relates to chimeric protein vaccines and methods of use thereof in the treatment of Staphylococcus aureus. One embodiment of the present invention provides a method of generating an immune response in a mammal, that includes administering to the mammal, a composition having a chimeric protein having at least one of: a portion of a cholera toxin, a portion of a heat-labile toxin, and a portion of a shiga toxin; and an antigen having at least one of: an antigenic material from S. aureus and an antigenic material from a S. aureus-specific polypeptide.
    Type: Grant
    Filed: July 3, 2019
    Date of Patent: March 3, 2020
    Assignee: Boise State University
    Inventor: Juliette Tinker
  • CHOLERA TOXIN CHIMERA AND ITS USE AS A STAPH VACCINE
    Publication number: 20190328860
    Abstract: The present invention relates to chimeric protein vaccines and methods of use thereof in the treatment of Staphylococcus aureus. One embodiment of the present invention provides a method of generating an immune response in a mammal, that includes administering to the mammal, a composition having a chimeric protein having at least one of: a portion of a cholera toxin, a portion of a heat-labile toxin, and a portion of a shiga toxin; and an antigen having at least one of: an antigenic material from S. aureus and an antigenic material from a S. aureus-specific polypeptide.
    Type: Application
    Filed: July 3, 2019
    Publication date: October 31, 2019
    Inventor: JULIETTE TINKER
  • Cholera toxin chimera and its use as a staph vaccine
    Patent number: 10383933
    Abstract: The present invention relates to chimeric protein vaccines and methods of use thereof in the treatment of Staphylococcus aureus. One embodiment of the present invention provides a method of generating an immune response in a mammal, that includes administering to the mammal, a composition having a chimeric protein having at least one of: a portion of a cholera toxin, a portion of a heat-labile toxin, and a portion of a shiga toxin; and an antigen having at least one of: an antigenic material from S. aureus and an antigenic material from a S. aureus-specific polypeptide.
    Type: Grant
    Filed: March 2, 2018
    Date of Patent: August 20, 2019
    Assignee: Boise State University
    Inventor: Juliette Tinker
  • CHOLERA TOXIN CHIMERA AND ITS USE AS A STAPH VACCINE
    Publication number: 20180280492
    Abstract: The present invention relates to chimeric protein vaccines and methods of use thereof in the treatment of Staphylococcus aureus. One embodiment of the present invention provides a method of generating an immune response in a mammal, that includes administering to the mammal, a composition having a chimeric protein having at least one of: a portion of a cholera toxin, a portion of a heat-labile toxin, and a portion of a shiga toxin; and an antigen having at least one of: an antigenic material from S. aureus and an antigenic material from a S. aureus-specific polypeptide.
    Type: Application
    Filed: March 2, 2018
    Publication date: October 4, 2018
    Inventor: Juliette Tinker
  • Cholera toxin chimera and its use as a staph vaccine
    Patent number: 9943582
    Abstract: The present invention relates to chimeric protein vaccines and methods of use thereof in the treatment of Staphylococcus aureus. One embodiment of the present invention provides a method of generating an immune response in a mammal, that includes administering to the mammal, a composition having a chimeric protein having at least one of: a portion of a cholera toxin, a portion of a heat-labile toxin, and a portion of a shiga toxin; and an antigen having at least one of: an antigenic material from S. aureus and an antigenic material from a S. aureus-specific polypeptide.
    Type: Grant
    Filed: August 11, 2014
    Date of Patent: April 17, 2018
    Assignee: Boise State University
    Inventor: Juliette Tinker
  • CHOLERA TOXIN CHIMERA AND ITS USE AS A STAPH VACCINE
    Publication number: 20180028638
    Abstract: The present invention relates to chimeric protein vaccines and methods of use thereof in the treatment of Staphylococcus aureus. One embodiment of the present invention provides a method of generating an immune response in a mammal, that includes administering to the mammal, a composition having a chimeric protein having at least one of: a portion of a cholera toxin, a portion of a heat-labile toxin, and a portion of a shiga toxin; and an antigen having at least one of: an antigenic material from S. aureus and an antigenic material from a S. aureus-specific polypeptide.
    Type: Application
    Filed: August 11, 2014
    Publication date: February 1, 2018
    Inventor: Juliette Tinker
  • CHOLERA TOXIN CHIMERA AND ITS USE AS A STAPH VACCINE
    Publication number: 20150017199
    Abstract: The present invention relates to chimeric protein vaccines and methods of use thereof in the treatment of Staphylococcus aureus. One embodiment of the present invention provides a method of generating an immune response in a mammal, that includes administering to the mammal, a composition having a chimeric protein having at least one of: a portion of a cholera toxin, a portion of a heat-labile toxin, and a portion of a shiga toxin; and an antigen having at least one of: an antigenic material from S. aureus and an antigenic material from a S. aureus-specific polypeptide.
    Type: Application
    Filed: August 11, 2014
    Publication date: January 15, 2015
    Inventor: Juliette Tinker
  • Cholera toxin chimera and its use as a staph vaccine
    Patent number: 8911748
    Abstract: The present invention relates to chimeric protein vaccines and methods of use thereof in the treatment of Staphylococcus aureus. One embodiment of the present invention provides a method of generating an immune response in a mammal, that includes administering to the mammal, a composition having a chimeric protein having at least one of: a portion of a cholera toxin, a portion of a heat-labile toxin, and a portion of a shiga toxin; and an antigen having at least one of: an antigenic material from S. aureus and an antigenic material from a S. aureus-specific polypeptide.
    Type: Grant
    Filed: May 17, 2013
    Date of Patent: December 16, 2014
    Assignee: Boise State University
    Inventor: Juliette Tinker
  • Cholera toxin chimera and its use as a staph vaccine
    Patent number: 8834898
    Abstract: The present invention relates to chimeric protein vaccines and methods of use thereof in the treatment of Staphylococcus aureus. One embodiment of the present invention provides a method of generating an immune response in a mammal, that includes administering to the mammal, a composition having a chimeric protein having at least one of: a portion of a cholera toxin, a portion of a heat-labile toxin, and a portion of a shiga toxin; and an antigen having at least one of an antigenic material from S. aureus and an antigenic material from a S. aureus-specific polypeptide.
    Type: Grant
    Filed: December 16, 2011
    Date of Patent: September 16, 2014
    Assignee: Boise State University
    Inventor: Juliette Tinker
  • Cholera Toxin Chimera and its Use as a Staph Vaccine
    Publication number: 20130266607
    Abstract: The present invention relates to chimeric protein vaccines and methods of use thereof in the treatment of Staphylococcus aureus. One embodiment of the present invention provides a method of generating an immune response in a mammal, that includes administering to the mammal, a composition having a chimeric protein having at least one of: a portion of a cholera toxin, a portion of a heat-labile toxin, and a portion of a shiga toxin; and an antigen having at least one of: an antigenic material from S. aureus and an antigenic material from a S. aureus-specific polypeptide.
    Type: Application
    Filed: May 17, 2013
    Publication date: October 10, 2013
    Inventor: Juliette Tinker
  • Cholera Toxin Chimera and its Use as a Staph Vaccine
    Publication number: 20130156802
    Abstract: The present invention relates to chimeric protein vaccines and methods of use thereof in the treatment of Staphylococcus aureus. One embodiment of the present invention provides a method of generating an immune response in a mammal, that includes administering to the mammal, a composition having a chimeric protein having at least one of: a portion of a cholera toxin, a portion of a heat-labile toxin, and a portion of a shiga toxin; and an antigen having at least one of an antigenic material from S. aureus and an antigenic material from a S. aureus-specific polypeptide.
    Type: Application
    Filed: December 16, 2011
    Publication date: June 20, 2013
    Inventor: Juliette Tinker